Riskpilot← Back to searchSign inGet full accessDr. Marco Vergari AB
ABActiveOrg 5594137340Labradorgatan 32Medical specialists activities · NACE 8622Est. 20221 employees
Revenue 2024
SEK 87K
-88% vs 2023
EBITDA margin
27.5%
-96% vs 2023
Equity ratio
89.6%
Financial strength
Net profit 2024
SEK 248K
-52% vs 2023
| Revenue | SEK 87K | -88% |
| EBITDA | SEK 24K | -96% |
| Net profit | SEK 248K | -52% |
| Total assets | SEK 417K | -46% |
| Equity | SEK 374K | -30% |
| Employees | 1 | — |
Legal name
Dr. Marco Vergari AB
Org number
5594137340
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 december 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultverksamhet inom hälso- och sjukvård, utbildning och kursverksamhet. Bolaget skall även förvalta aktier i andra företag, upparbetade vinstmedel medelst värdepapper och fastigheter samt därmed förenlig verksamhet.
Address
Labradorgatan 32
Email
vergarimedical@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 748 | 87 |
| Staff expenses | −51 | −11 |
| EBITDA | 643 | 24 |
| Depreciation & amort. | — | — |
| EBIT | 643 | 24 |
| Net financials | 0 | 234 |
| Profit before tax | 643 | 251 |
| Tax | −133 | −4 |
| Net profit | 511 | 248 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 773 | 417 |
| Equity | 536 | 374 |
| Long-term debt | — | — |
| Short-term debt | 237 | 37 |
| Total debt | 237 | 37 |
EBITDA margin
27.5%
This company
15.8%
Market median
+74% vs market
20232024
Equity ratio
89.6%
This company
38.2%
Market median
+135% vs market
20232024
Return on equity
66.3%
This company
18.4%
Market median
+260% vs market
20232024
Net profit margin
284.6%
This company
8.1%
Market median
+3414% vs market
20232024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20232024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
KH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2026 | |
| Former (4) | ||
| Deputy Board Member | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Marco Vergari AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klara Hanna L Sonesson Göransson | Deputy Chief Executive Officer | 0 companies |
| Marco Antonio Francesco Vergari | Chief Executive Officer | 0 companies |
| Angela Francesca Rotondo | Deputy Board Member | 0 companies |
| Luca Enrico Gaetano Vergari | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |